pharmastem

REVERSED

1700 Chemical & Materials Engineering
1716 Ex Parte Kitsunai et al 10/912,177 GAUDETTE 103(a) ANTONELLI, TERRY, STOUT & KRAUS, LLP EXAMINER KACKAR, RAM N

1783 Ex Parte Brennan 11/303,412 GARRIS 103(a) THE PROCTER & GAMBLE COMPANY EXAMINER GUGLIOTTA, NICOLE T

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3651 Ex Parte Blanchard et al 11/442,726 BAHR 102(e)/102(b)/103(a) Avery Dennison Corporation EXAMINER NICHOLSON III, LESLIE AUGUST

AFFIRMED-IN-PART

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3689 Ex Parte Lehr et al 10/045,151 PETRAVICK 102(b) 102(b)/103(a) 37 C.F.R. § 41.50(b) 112(2) HEWLETT-PACKARD COMPANY EXAMINER FISHER, MICHAEL J
AFFIRMED

1700 Chemical & Materials Engineering
1727 Ex Parte Stegink et al 10/961,263 PER CURIAM 102(b)/103(a) 3M INNOVATIVE PROPERTIES COMPANY EXAMINER BEST, ZACHARY P

1775 Ex Parte Haq 11/688,491 PER CURIAM 102(b)/103(a) David W. Highet, VP & Chief IP Counsel Becton, Dickinson and Company EXAMINER BEISNER, WILLIAM H

2100 Computer Architecture and Software
2163 Ex Parte Faiman et al 11/035,559 COURTENAY 102(e) IBM CORPORATION EXAMINER LIE, ANGELA M

2189 Ex Parte Dwyer et al 09/975,764 THOMAS 103(a) RYAN, MASON & LEWIS, LLP EXAMINER LANE, JOHN A

“Admissions in the specification regarding the prior art are binding on the patentee for purposes of a later inquiry into obviousness.” PharmaStem Therapeutics, Inc. v. ViaCell, Inc., 491 F.3d 1342, 1362 (Fed. Cir. 2007) (citations omitted).
REHEARING

DENIED

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3662 Ex Parte Spanke 10/712,005 HORNER 103(a) BACON & THOMAS, PLLC EXAMINER SOTOMAYOR, JOHN B